A Descriptive Study of Nosocomial Infections in an Adult Intensive Care Unit in Fiji: 2011-12 by Naidu, Keshni et al.
Research Article
A Descriptive Study of Nosocomial Infections in an Adult
Intensive Care Unit in Fiji: 2011-12
Keshni Naidu,1 Ilisapeci Nabose,2 Sharan Ram,1 Kerri Viney,3,4
Stephen M. Graham,5,6 and Karen Bissell5,7
1 College of Medicine, Nursing & Health Sciences, Fiji National University, Suva, Fiji
2 Colonial War Memorial Hospital, Ministry of Health, Suva, Fiji
3 Public Health Division, Secretariat of the Pacific Community, Noumea, New Caledonia
4National Centre for Epidemiology and Population Health, Research School of Population Health,
Australian National University, Canberra, Australia
5 International Union Against Tuberculosis and Lung Disease, Paris, France
6Centre for International Child Health, Department of Paediatrics,
University of Melbourne and Murdoch Children Research Institute, Royal Children’s Hospital, Melbourne, VIC, Australia
7The University of Auckland, Auckland, New Zealand
Correspondence should be addressed to Keshni Naidu; keshni78@gmail.com
Received 26 June 2014; Accepted 25 August 2014; Published 17 September 2014
Academic Editor: Peter Leggat
Copyright © 2014 Keshni Naidu et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Nosocomial infections in an intensive care unit (ICU) are common and associated with a high mortality but there are no
published data from the Oceania region. A retrospective study in Fiji’s largest ICU (2011-12) reported that 114 of a total 663 adult
ICU admissions had bacteriological culture-confirmed nosocomial infection. The commonest sites of infection were respiratory
and bloodstream. Gram negative bacteria were the commonest pathogens isolated, especially Klebsiella pneumoniae (extended-
spectrum 𝛽-Lactamase-producing), Acinetobacter, and Pseudomonas species. Mortality for those with a known outcome was 33%.
Improved surveillance and implementation of effective preventive interventions are needed.
1. Introduction
Health-care-associated (or nosocomial) infection is a major
problem in hospitals worldwide and the prevalence is two- to
threefold higher in developing countries compared to Europe
or USA [1, 2]. The incidence is particularly high in intensive
care units (ICUs) compared to non-ICUwards in the hospital
as ICU patients have a range of severe comorbidities and the
use of invasive devices during their management is very com-
mon [3]. Reports froma range of ICU settings including those
in developing countries consistently show a high burden of
device-associated nosocomial infections [4–6]. Nosocomial
infections are caused by a wide range of pathogens, and
ventilator-associated pneumonia and central line infections
are common sites of infections and are associated with
high mortality—as high as 50%. Nosocomial infections are
associated with an increase in crude mortality, length of stay
in ICU, and hospital costs [7–10].
There are no published data reporting the prevalence of
nosocomial infections in Fiji. Such information is required to
describe the current epidemiology and to improve infection
control practices in the adult ICU. This retrospective study
aimed to describe bacteriological culture-confirmed nosoco-
mial infections in Fiji’s largest adult ICU.
2. Materials and Methods
2.1. Study Design and Setting. This was a retrospective,
descriptive study of bacteriological culture-confirmed noso-
comial infections in an adult ICU in 2011 and 2012. The
study was conducted at the Colonial War Memorial Hospital
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(CWMH) in Suva, Fiji.The adult ICUward at theCWMHhas
6 beds and is the largest ICU ward in Fiji. There is a separate
ICU ward for children and neonates (0–14 years). The adult
ICU provides care for both ventilated and nonventilated
patients and a mix of medical and general surgical patients.
Patients may be admitted directly from the community or
from other hospital wards.
2.2. Study Population. The study only included patients
with clinical features of invasive sepsis who had a bacterial
pathogen isolated on culture from at least one specimen
taken from the patient more than 48 hours after admission to
the ICU, that is, those with clinically suspected nosocomial
sepsis that was microbiologically confirmed. When the onset
of invasive sepsis is clinically suspected on the basis of
the patient developing evidence of a systemic inflammatory
response syndrome (SIRS, see Box 1), samples from venous
blood, body sites, and devices are sent for bacterial culture.
The attending clinician selects the samples to be sent as
clinically indicated on the basis of the likely site of infection.
Patients admitted to the ICU with sepsis were not included
unless they developed new signs of SIRS (Box 1)more than 48
hours after admission. Patients with suspected sepsis without
microbiological confirmation were also not included.
Blood cultures were processed using the BACT/ALERT
3D system (BioMerieux, Marcy L’Etoile, France) and incu-
bated at 36∘C for 7 days. If a blood culture bottle was
flagged positive, a Gram stain was performed on one drop
of the culture fluid. Subculture was performed using selective
and nonselective agar depending on the Gram stain result.
Gramnegative organismswere identified using theMicrobact
Identification Kit (Oxoid, Basingstoke, UK).
Data were sourced from the infection control surveillance
records and the ICU patient records with cross-checking
between these records and the microbiology laboratory
records. Data collected for all ICU admissions for 2011-2012
included numbers of admissions, devices used, and number
of days the devices were used. The patient name was used
for cross-checking between registers but not included in data
entry or data storage.
Data were collected in a structured proforma using a
unique identification number and the following variables
were entered: age, date of admission, date of specimen
collection, length of stay in ICU, and bacterial pathogens
isolated and fromwhich specimen the pathogen was isolated.
Respiratory specimens include those that were taken from
the respiratory tract—usually aspiration of endotracheal
or tracheostomy tubes from ventilated patients—or pleural
aspirates while blood stream infections include those taken
from peripheral blood cultures, those samples taken through
a venous cannula device such as a central venous line and
catheter tips.
Data were double entered into EpiData version 3.1 (Epi-
DataAssociation, Odense, Denmark).The rate of nosocomial
infections was calculated by dividing the number of patients
with nosocomial infections by the total number of patients in
Table 1: Characteristics of bacteriologically-confirmed nosocomial
infections from an adult intensive care unit 2011-2012.
2011
𝑁 = 58
2012
𝑁 = 56
Total
𝑁 = 114
Age
15–30 yrs 15 (26) 14 (25) 29
31–60 yrs 30 (52) 29 (52) 59
61–100 yrs 12 (21) 12 (21) 24
Unknown — 2 (4) 2
Sex
Male 38 (66) 34 (60) 72
Female 19 (33) 21 (38) 40
Unknown 2 (4) 2
Admission status
Direct admission 15 (26) 19 (34) 34
Transferred 43 (74) 36 (64) 79
Unknown 1 (2) 1
Length of stay
1–7 days 18 (31) 8 (14) 26
8–14 days 20 (34) 22 (39) 42
15–21 days 10 (17) 7 (13) 17
22–31 days 7 (12) 11 (20) 18
31 days and more 2 (3) 7 (13) 9
Unknown 1 (2) 1 (2) 2
Mechanical Ventilation
Ventilated 57 (98) 54 (96) 111
Not ventilated 0 1 (2) 1
Unknown 1 (2) 1 (2) 2
Patient outcomes
Transferred from ICU 35 (60) 23 (41) 58
Deceased 16 (28) 22 (39) 38
Unknown 7 (12) 11 (20) 18
the ICU during the same study period. Numbers of isolates
per site of specimen are presented.
3. Results
There were 663 patients admitted to the ICU during the two-
year study period. This represented 2891 total patient days
of admission during which patients were ventilated for 2175
days. Of the 663 admissions, 114 (17%) developed culture-
confirmed nosocomial sepsis. Table 1 lists the characteristics
of the study patients. The majority of the patients had prior
admission to other wards before admission to ICU. Males
were more commonly represented than females and almost
all patients had been mechanically ventilated with a median
period of 8 days of ventilation.
Table 2 lists the bacterial pathogens isolated and the sites
from which they were isolated. The largest proportion was
from respiratory tract specimens. There were 437 isolates
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Temperature (onset of fever) >38∘C
Increased white cell count >12,0003
Increased heart rate >90 beats per minute
Tachypnoea >20
New chest infiltrates
Purulent endotracheal/tracheal discharges
Box 1: Indicators of a systemic inflammatory response.
Table 2: Distribution of bacterial pathogens associated with nosocomial infection in relation to site of specimen.
Pathogen Site of pathogen Total
𝑁 = 437Respiratory tract
𝑁 = 125
Blood
𝑁 = 122
Surgical site
𝑁 = 102
Urinary tract
𝑁 = 88
Klebsiella pneumoniae
(ESBL producing#) 34 (27%) 21 (17%) 18 (18%) 21 (24%) 94 (22%)
Acinetobacter species 33 (26%) 21 (17%) 18 (18%) 20 (23%) 92 (21%)
Pseudomonas aeruginosa 24 (19%) 11 (9%) 25 (25%) 13 (15%) 73 (17%)
Enterobacter species 8 (6.4%) 9 (7%) 11 (11%) 5 (6%) 33 (8%)
Coagulase-negative
Staphylococci 1 (0.8%) 20 (16%) 1 (0.9%) 8 (9%) 30 (7%)
Escherichia coli 2 (1.6%) 13 (11%) 2 (2%) 5 (6%) 22 (5%)
Other Klebsiella 6 (4.8%) 2 (1.6%) 6 (6%) 5 (6%) 19 (4%)
Other Gram negative
species 5 (4%) 6 (5%) 6 (6%) 0 17 (4%)
Citrobacter species 2 (1.6%) 2 (1.6%) 2 (2%) 3 (3%) 9 (2%)
MRSA# 1 (0.8%) 1 (0.8%) 1 (0.9%) — 3 (0.2%)
Others 9 (7.2%) 16 (13%) 12 (12%) 8 (9%) 45 (1.1%)
#ESBL: extended spectrum 𝛽-lactamase; MRSA: methicillin resistant Staphylococcus aureus.
from 114 patients and so most patients had isolates cultured
from multiple sites. Of patients, 66% had isolates from a
respiratory specimen (endotracheal tube or pleural fluid),
49% from a urinary specimen (indwelling catheter or clean
catch), 67% from a blood specimen (peripheral or central
line), and 41% from a surgical site (wound swab or surgical
drain). Gramnegative bacteria such asKlebsiella pneumoniae,
Acinetobacter species, and Pseudomonas aeruginosa were
the commonest isolates. K. pneumoniae (extended-spectrum
𝛽-Lactamase (ESBL) producing) was isolated from blood
and urine in 21% of patients simultaneously. Coagulase-
negative staphylococci were most commonly isolate from
blood. Pseudomonas aeruginosa was the commonest isolate
from surgical site specimens.
Outcome was known in 84% (96/114) patients and 40%
(38/96) with known outcome died in ICU (Table 1). Of 63
patients with a bacterial isolate from the blood and a known
outcome, 21 (33%) died, compared to 50% (16/32) among
those with a known outcome but without a bacterial isolate
from the blood. Of those that died, 55% (21/38) had a blood
stream infection.
4. Discussion
This study provides original descriptive data from Fiji of
common nosocomial bacterial infections in ICU. A recent
global systematic review of the published literature on the
burden of nosocomial infections in developing countries did
not identify previously published data from the Pacific Island
region [1]. The commonest sites of infection were respiratory
tract and bloodstream infections, andGramnegative bacteria
were the main pathogens isolated from ICU patients. These
findings are consistent with other studies from developing
countries [1, 4–11].
Mortality was very high among these ICU patients with
nosocomial infections. High mortality has been previously
reported from developing countries ICUs [6, 10]. It is difficult
to ascertain the additional attributable risk of nosocomial
infection to mortality in these patients and settings as overall
mortality is high in ICU patients and length of stay of ICU
patients is linked with the comorbidities that the patients
have prior to admission to ICU. The average length of
stay for our patients was 4 days but with a wide range of
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up to over 30 days—such as for patients with trauma or
Guillain-Barre syndrome. Patients in the ICUwere ventilated
for the majority of the time spent in ICU, on average for
75% of their stay. However, we were unable to determine
relationships between nosocomial infection and outcomes
such as mortality and length of stay in our retrospective
study. A previous study estimated that ventilator-associated
pneumonia, which is one of the commonest ICU-related
nosocomial infections, was associated with a 14% increase in
risk ofmortality and a prolonging of the ICU stay by two days
[10].
In this study, Gram negative bacteria were the predom-
inant pathogens isolated with Klebsiella, Acinetobacter, and
Pseudomonas the commonest isolate. These pathogens are
commonly isolated from patients in ICUs and the prevalence
of pathogens can change over time [3–6, 12–14]. There was
a recent outbreak of Acinetobacter in the ICU of CWMH
during the study period (August–December 2012). Gram
positives were less prevalent with the commonest being
coagulase-negative staphylococci and it is difficult to know
whether this is a pathogen or skin contaminant [13]. It was
most commonly isolated from blood specimens that are
often taken through intravenous lines. Notably, methicillin-
resistant Staphylococcus aureus was not commonly isolated.
Nosocomial pathogens are frequently resistant to multiple
antibiotics. We do not present antibiotic susceptibility data
except to note that ESBL-producing Klebsiella was very
common. K. pneumoniae is well recognized to have emerged
as important ESBL-producing bacteria, and the other com-
mon bacteria found in this study such as Acinetobacter and
Pseudomonas can also be ESBL-producing [13].
This study has a number of important limitations. It is
a retrospective study that relies on previous data records
for which accuracy and completeness cannot be validated.
However, protocols and recording are structured and have
been used for infection control purposes in the CWMH for
many years. Data on the use of all devices over the study
periodwere not available and so rates of nosocomial infection
associated with specific device utilization over time could not
be calculated. The data on outcome were also incomplete.
5. Conclusion
Despite these limitations, this study provides important
baseline data that strongly suggest that infection control
practices could be improved. There are known interventions
that can reduce the burden of nosocomial infections in ICUs
even in the resource-limited setting [15–19]. There needs to
be improved recording and ongoing surveillance in order to
monitor the burden of infections and evaluate interventions
that can prevent nosocomial infections and reduce the risk of
outbreaks.
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